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TO THE EDITOR
Epidermolytic hyperkeratosis (EH; MIM
113800), also termed bullous congeni-
tal ichthyosiform erythroderma, is a
keratinization disorder characterized
by erythema and widespread blister
formation at birth that is replaced by
progressive hyperkeratosis later in life
(Arin and Mu¨ller, 2007). The causes of
EH in most cases are the dominant
mutations in the genes encoding kera-
tins, K1 and K10, which lead to clump-
ing of keratin intermediate filaments in
suprabasal keratinocytes. The majority of
mutations are located at the highly
conserved helix boundary motifs of both
keratins, and a genetic ‘‘hotspot’’ has
been identified in K10 affecting an
evolutionarily highly conserved arginine
residue (p.Arg 156) (Rothnagel et al.,
1993; McLean et al., 1994). Recently, a
recessive form of EH has been identified
that is due to a nonsense mutation in the
KRT10 gene leading to loss of K10
expression in the affected homozygous
individuals (Mu¨ller et al., 2006).
In this study, we carried out mole-
cular analysis in a family of Sudanese
descent with several lines of blood
relations (Figure 1a). At birth, the
affected girl presented with widespread
erythema and superficial erosions lo-
cated predominantly on the trunk and
on the proximal extremities, and in the
face (Figure 1b). Shedding of thick
plates without erosions starting around
the umbilicus was reminiscent of a
collodion presentation. During the in-
itial days of life, she became increas-
ingly somnolent and developed hyper-
natremia requiring intensive neonatal
care. The consanguineous parents as
well as the 3-year-old brother did not
show any skin disease. A similar severe
picture was seen in a previously repor-
ted family with recessive EH (Mu¨ller
et al., 2006), and diffuse skin blister-
ing and erosions at birth were also
reported in another child with recessive
EH (Tsubota et al., 2008). Palmoplantar
sites were not affected in all four
patients described to date, similar to
autosomal dominant EH caused by
KRT10 mutations. Skin biopsy speci-
mens were taken by excision biopsy
under local anesthesia from the affected
proband, and were processed for rou-
tine histology, immunofluorescence,
and electron microscopy, essentially
as described in Mu¨ller et al., 2006.
Genomic DNA from all family mem-
bers was extracted from peripheral
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Figure 1. Clinical presentation, ultrastructural and immunofluorescence analysis in recessive EH.
(a) The affected girl is the second child of consanguineous parents. The simplified pedigree shows several
lines of blood relations within the parental families. The parents as well as the brother do not show any skin
disease. (b) The clinical presentation at birth was reminiscent of a collodion baby. (c) Histopathology is
typical of epidermolytic hyperkeratosis (EH) with suprabasal cytolysis. Magnification  100. Bar¼ 100mm.
(d) Electron microscopy of the granular layer reveals two distinct aggregates within keratinocytes: keratin
clumps (KC) and more electron dense keratohyalin granules (KHG). Bar¼ 2.5mm. (e) Immunohistology
shows absence of epidermal K10 protein in the affected girl. Normal control (f). Bar¼ 100mm.
Abbreviations: EH, epidermolytic hyperkeratosis; K, keratin protein; KRT, keratin gene; NMD, nonsense-
mediated decay; PTC, premature termination codon
blood samples using standard methods.
The study was conducted after obtain-
ing a written informed consent and
following Institutional Review Board
approval, and followed the Declaration
of Helsinki Principles. Histopathology
of a skin biopsy taken shortly after birth
was typical for EH with vacuolar
degeneration of suprabasal keratino-
cytes and coarse keratohyalin granules
in the thickened granular layer (Figure
1c). Electron microscopy in low magni-
fication showed cytolysis, and loose
and irregularly shaped electrodense
clumps within the keratinocytes of
the suprabasal layers of the epidermis.
The keratin clumps showed a nearly
homogenous, amorphous structure
(Figure 1d), which is not seen in auto-
somal dominant EH, wherein the
clumps regularly maintain a filamen-
tous, thready aspect. Immunofluores-
cence analysis using specific mono-
clonal mouse antibodies (LH2 and
DE-K10), which are directed against
the amino-terminal part of the K10
protein, showed the absence of K10
protein in the epidermis of the affected
child (Figure 1e).
For KRT1 and KRT10 mutation ana-
lysis, the PCR fragments were amplified
using exon-specific primer pairs as
described earlier (Mu¨ller et al., 2006).
In the affected child, direct sequencing
disclosed a homozygous insertion
of C at nucleotide 1,325 in KRT10
(c.1325insC). This frameshift mutation
leads to a premature termination codon
(PTC) (TGA) six codons downstream in
the same exon. In terms of its effect on
protein translation, the mutation is
designated as p.Lys439fsX6. Both par-
ents and the unaffected brother are
heterozygous carriers of the mutation
(Figure 2a). A common polymorphism
could be excluded by the absence of the
mutation in 50 unrelated control DNA
samples, and no other mutation was found
in the entire KRT1 and KRT10 genes.
To confirm that the reported muta-
tion causes nonsense-mediated decay
of the mRNA (NMD), we carried out
quantitative real-time reverse transcrip-
tase PCR using a 7300 real-time PCR
System (Applied Biosystems, Foster
City, CA). Total RNA was extracted
from keratinocytes according to
the manufacturer’s protocol (Qiagen,
Hilden, Germany). Primers specific for
KRT10 exon 2/3, exon 4/5, and exon
5/6 were used, and the samples were
analyzed in triplicates. S26 mRNA was
used as the endogenous reference gene,
as it does not exhibit significant expres-
sion changes between wild type and
recessive EH. The transcript levels
of wild type vs. recessive EH were
assessed by unpaired two-tailed t-test. A
significant reduction of specific KRT10
mRNA was found in the skin of the
homozygous patient compared with a
normal control (Figure 2b). This finding
confirms that the here described
nonsense mutation does not generate
a truncated K10 gene product, but
leads to instability and degradation of
the mutant transcript by NMD in homo-
zygous patients. The NMD detects
mRNAs harboring PTCs and commits
these transcripts to rapid decay. During
mRNA splicing, protein complexes
called exon junction complexes assem-
ble close to each exon–exon junction
(Lejeune and Maquat, 2005). During
the initial round of translation, the
translation machinery displaces the
exon junction complexes associated
with the transcript as it proceeds with
elongation. If the mRNA contains a
PTC located more than a certain range
upstream the last exon–exon junction
(for example, 50–55 nucleotides in the
beta globin gene), at least one exon
junction complex will remain on the
mRNA thereby triggering NMD (Silva
and Romao, 2009). For the KRTs, the
first description of a PTC leading to
transcript instability has been shown
for KRT14 in autosomal recessive
epidermolysis simplex bullosa (Chan
et al., 1994). The present mutation
(p.Lys439fsX6) together with both pre-
viously reported mutations in recessive
EH, p.Gln434X (Mu¨ller et al., 2006)
and p.Cys427X (Tsubota et al., 2008),
are located 461, 476, and 497 nucleo-
tides upstream to the 30-most exon–
exon junction, which supports the
concept that in KRTs, PTCs are
expected to be targeted by NMD when
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Figure 2. Molecular basis of recessive EH in the present family. (a) Direct sequencing revealed a
homozygous nonsense mutation in exon 6 of KRT10 in the affected individual, whereas the unaffected family
members are heterozygous carriers of the mutation. The insertion mutation results in a frameshift mutation
and a premature termination codon (TGA) six amino acids downstream (p.Lys439fsX6). (b) Quantitative
real-time PCR analysis shows a significant decrease of specific KRT10 mRNA in the skin of the homozygous
patient compared with a normal control. Levels of the heterozygous father were about 50% of wild type.
The data are presented as the fold change in KRT10 mRNA level normalized to the S26 mRNA. The difference
in expression of KRT10 mRNA between wild type and recessive Epidermolytic hyperkeratosis (EH) was
statistically significant (*Po0.05). Depicted are means and SEM of three experiments. (c) All mutations
reported to date in recessive EH (present mutation, p.Lys439fsX6, together with both previously reported
mutations, p.Gln434X (Mu¨ller et al., 2006) and p.Cys427X (Tsubota et al., 2008)) are located in close
proximity at the end of the 2B domain of K10, just upstream of the highly conserved helix termination peptide
(red area). The mutation ‘‘hotspots’’ of autosomal dominant EH are depicted in red. The color version of this
figure is available on the html full text version of the manuscript.
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located more than 92 nucleotides up-
stream to the 30-most exon–exon junc-
tion (Mu¨ller et al., 2006). K10 transcript
levels in the normal skin of the hetero-
zygous father were B50% compared
with the wild type (Figure 2b). Hetero-
zygous family members are clinically
unaffected, which indicates that one
K10 allele is sufficient to maintain a
normal phenotype.
In the previously reported homozy-
gous EH patients (Mu¨ller et al., 2006)
and in the present proband, K6, K16, and
K17 are upregulated in the absence of
human K10 protein and show a maximal
expression at the sites of cytolysis (data
not shown). In addition, suprabasal
persistence of the basal keratin, K14,
was found in our patient and in the
recessive EH patient reported by Tsubota
et al. (2008). In the K10 knockout
mouse, decreased proteolysis and supra-
basal persistence of the basal keratins,
K5, K14, and K15, were shown, and
keratin aggregates were found to consist
of residual K1 that formed atypical
heterodimers with K14 (Reichelt et al.,
2001). Formation of instable atypical
heterodimers between residual K1 and
another type I keratin, for example, K16
or K17, which form relatively poor
intermediate filaments compared with
those built up from keratins constitutively
expressed in the epidermis (Takahashi
et al., 1994; Paladini et al., 1996), could
additionally contribute to skin fragility
and cytolysis in recessive EH.
In conclusion, the characteristic
ultrastructural picture consisting of
sparse keratin filaments and keratin
clumps that show a nearly homogenous,
amorphous structure should prompt a
detailed analysis of the pedigree to
search for parental consanguinity and a
recessive inheritance. All reported muta-
tions in recessive EH to date are located
in close proximity in the 2B domain of
K10 (Figure 2c), suggesting a genetic
hotspot in recessive EH. Expanding
the catalog of known mutations in this
disorder is important with respect
to molecular diagnosis and genetic
counseling.
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TO THE EDITOR
Most symptoms of allergic disease are
caused by mast cell (MC) activation and
subsequent release of mediators, parti-
cularly histamine (Metz and Maurer,
2007; Metz et al., 2008). Research
shows that preformed histamine is stored
in large amounts in cutaneous MC
granules (Metz and Maurer, 2007).
Currently, the most common way to
treat MC-driven diseases, such as allergicAbbreviations: Ca, calcium; MC, mast cell
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